Expression of Indoleamine 2, 3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial. (March 2019)

Record Type:
Journal Article
Title:
Expression of Indoleamine 2, 3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial. (March 2019)
Main Title:
Expression of Indoleamine 2, 3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial
Authors:
Kruger, S.
Ormanns, S.
Roesgen, V.
Legenstein, M.
Haas, M.
Westphalen, C.B.
Duewell, P.
Schnurr, M.
Kirchner, T.
von Bergwelt-Baildon, M.
Heinemann, V.
Boeck, S.
Abstract:
Is Part Of:
European journal of cancer. Volume 110(2019)Supplement 1
Journal:
European journal of cancer
Issue:
Volume 110(2019)Supplement 1
Issue Display:
Volume 110, Issue 2019 (2019)
Year:
2019
Volume:
110
Issue:
2019
Issue Sort Value:
2019-0110-2019-0000
Page Start:
S16
Page End:
Publication Date:
2019-03
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.ejca.2019.01.058 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
9965.xml